Literature DB >> 20807601

An integrated approach for the rational design of nanovectors for biomedical imaging and therapy.

Biana Godin1, Wouter H P Driessen, Bettina Proneth, Sei-Young Lee, Srimeenakshi Srinivasan, Rolando Rumbaut, Wadih Arap, Renata Pasqualini, Mauro Ferrari, Paolo Decuzzi.   

Abstract

The use of nanoparticles for the early detection, cure, and imaging of diseases has been proved already to have a colossal potential in different biomedical fields, such as oncology and cardiology. A broad spectrum of nanoparticles are currently under development, exhibiting differences in (i) size, ranging from few tens of nanometers to few microns; (ii) shape, from the classical spherical beads to discoidal, hemispherical, cylindrical, and conical; (iii) surface functionalization, with a wide range of electrostatic charges and biomolecule conjugations. Clearly, the library of nanoparticles generated by combining all possible sizes, shapes, and surface physicochemical properties is enormous. With such a complex scenario, an integrated approach is here proposed and described for the rational design of nanoparticle systems (nanovectors) for the intravascular delivery of therapeutic and imaging contrast agents. The proposed integrated approach combines multiscale/multiphysics mathematical models with in vitro assays and in vivo intravital microscopy (IVM) experiments and aims at identifying the optimal combination of size, shape, and surface properties that maximize the nanovectors localization within the diseased microvasculature. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20807601      PMCID: PMC3998831          DOI: 10.1016/S0065-2660(10)69009-8

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  113 in total

1.  A theoretical model for the margination of particles within blood vessels.

Authors:  P Decuzzi; S Lee; B Bhushan; M Ferrari
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

Review 2.  Nanotechnology and cancer.

Authors:  James R Heath; Mark E Davis
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

3.  Nanogeometry: beyond drug delivery.

Authors:  Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03       Impact factor: 39.213

4.  Alpha v integrins as receptors for tumor targeting by circulating ligands.

Authors:  R Pasqualini; E Koivunen; E Ruoslahti
Journal:  Nat Biotechnol       Date:  1997-06       Impact factor: 54.908

5.  Margination of leukocytes in blood flow through small tubes.

Authors:  H L Goldsmith; S Spain
Journal:  Microvasc Res       Date:  1984-03       Impact factor: 3.514

6.  Aminopeptidase A is a functional target in angiogenic blood vessels.

Authors:  Serena Marchiò; Johanna Lahdenranta; Reinier O Schlingemann; Donatella Valdembri; Pieter Wesseling; Marco A Arap; Amin Hajitou; Michael G Ozawa; Martin Trepel; Ricardo J Giordano; David M Nanus; Henri B P M Dijkman; Egbert Oosterwijk; Richard L Sidman; Max D Cooper; Federico Bussolino; Renata Pasqualini; Wadih Arap
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

Review 7.  Antibiological barrier nanovector technology for cancer applications.

Authors:  Jason Sakamoto; Ananth Annapragada; Paolo Decuzzi; Mauro Ferrari
Journal:  Expert Opin Drug Deliv       Date:  2007-07       Impact factor: 6.648

8.  Size of IgG-opsonized particles determines macrophage response during internalization.

Authors:  M Koval; K Preiter; C Adles; P D Stahl; T H Steinberg
Journal:  Exp Cell Res       Date:  1998-07-10       Impact factor: 3.905

9.  Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

Authors:  P A Vasey; S B Kaye; R Morrison; C Twelves; P Wilson; R Duncan; A H Thomson; L S Murray; T E Hilditch; T Murray; S Burtles; D Fraier; E Frigerio; J Cassidy
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

Review 10.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

View more
  21 in total

1.  Cardiovascular nanomedicine: a posse ad esse.

Authors:  Biana Godin; Mauro Ferrari
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

Review 2.  Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.

Authors:  Arvind Chopra; Liang Shan; W C Eckelman; Kam Leung; Martin Latterner; Stephen H Bryant; Anne Menkens
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

3.  Pharmacokinetic/Pharmacodynamics Modeling of Drug-Loaded PLGA Nanoparticles Targeting Heterogeneously Vascularized Tumor Tissue.

Authors:  Hunter A Miller; Hermann B Frieboes
Journal:  Pharm Res       Date:  2019-11-26       Impact factor: 4.200

4.  Evaluation of uptake and distribution of gold nanoparticles in solid tumors.

Authors:  Christopher G England; André M Gobin; Hermann B Frieboes
Journal:  Eur Phys J Plus       Date:  2015-11-19       Impact factor: 3.911

Review 5.  The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.

Authors:  Nazanin Hoshyar; Samantha Gray; Hongbin Han; Gang Bao
Journal:  Nanomedicine (Lond)       Date:  2016-03-22       Impact factor: 5.307

Review 6.  Systems approaches to design of targeted therapeutic delivery.

Authors:  Jacob W Myerson; Jacob S Brenner; Colin F Greineder; Vladimir R Muzykantov
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-05-06

7.  Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.

Authors:  Jonathan O Martinez; Christian Boada; Iman K Yazdi; Michael Evangelopoulos; Brandon S Brown; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Small       Date:  2012-12-16       Impact factor: 13.281

8.  Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.

Authors:  Biana Godin; Ciro Chiappini; Srimeenakshi Srinivasan; Jenolyn F Alexander; Kenji Yokoi; Mauro Ferrari; Paolo Decuzzi; Xuewu Liu
Journal:  Adv Funct Mater       Date:  2012-10-23       Impact factor: 18.808

Review 9.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

10.  Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.

Authors:  Kenji Yokoi; Biana Godin; Carol J Oborn; Jenolyn F Alexander; Xuewu Liu; Isaiah J Fidler; Mauro Ferrari
Journal:  Cancer Lett       Date:  2012-09-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.